Guardant Health (GH) Tops Q3 EPS by 29c ; Offers Guidance

Guardant Health (NASDAQ: GH) reported Q3 EPS of ($0.45), $0.29 better than the analyst estimate of ($0.74). Revenue for the quarter came in at $191.5 million versus the consensus estimate of $170.49 million.

GUIDANCE:

Guardant Health sees FY2024 revenue of $720-725 million, versus the consensus of $695.5 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Trump administration proposes looser oil drilling rules
• Lockheed, RTX, Boeing, L3Harris expected to meet with Trump - WSJ